AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vaccine failure contributes to mumps outbreak in vaccinated children.

Vaccine Weekly

| October 06, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Vaccine failure contributed to an outbreak of mumps in a vaccinated child population.

According to recent research published in the journal Vaccine, "In Belgium, children are immunized against measles-mumps-rubella (MMR) in a two-dose schedule at the age of 15 months and 11 years. Despite these recommendations, epidemics of mumps still occur. During an outbreak of mumps in Bruges (Belgium), 105 cases were registered in seven schools (age group 3-12 years)."

"Lower than optimal vaccination coverage, inadequate vaccination schedule, and a combination of primary and/or secondary vaccine failure are considered as possible reasons for the outbreak as described in the article," said Corinne Vandermeulen at Katholieke Universiteit Leuven and collaborators in Belgium. "The role of secondary vaccine failure is highlighted."

...

Related articles from newspapers, magazines, journals, and more
Genetic basis for measles vaccine failure outlined.
Newspaper article from: Vaccine Weekly July 21, 2004 700+ words
...basis for measles vaccine failure in a recent issue...vaccines and address vaccine failure that results from...basis for measles vaccine failure. Acta Paediat...article was prepared by Vaccine Weekly editors from staff...
Phase III Cancer Vaccine Failure Deflates Oxford BioMedica.
Magazine article from: BIOWORLD Today Moran, Nuala July 14, 2008 700+ words
Byline: Nuala Moran, BioWorld Today Correspondent LONDON -- Oxford BioMedica plc's share price plunged 60.3 percent to 7.35 pence (US15 cents) on Friday when the company said the Phase III trial of its cancer vaccine TroVax would not reach its primary endpoint of overall survival in renal cancer.
Penn-Wistar Team Gains Insight Into HIV Vaccine Failure.
News wire article from: Ascribe Higher Education News Service July 20, 2009 700+ words
Byline: The Wistar Institute PHILADELPHIA, July 20 (AScribe Newswire) -- A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast
Penn-Wistar team gains insight into HIV vaccine failure.(Report)
Newspaper article from: NewsRx Health & Science August 9, 2009 700+ words
PHILADELPHIA - (July 20, 2009) - A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1
Lack of circumcision, immunity linked to HIV vaccine failure.(Infectious...
Magazine article from: Family Practice News Mahoney, Diana April 1, 2008 700+ words
BOSTON -- The increased risk of HIV infection observed in the now-defunct trial of Merck's experimental trivalent HIV vaccine V520 was greatest in uncircumcised men with high preexisting immunity to the vaccine's delivery vector, the adenovirus type 5, according to a post hoc analysis of the trial
Lack of circumcision tied to HIV vaccine failure.(Infectious Diseases)
Magazine article from: Internal Medicine News May 15, 2008 700+ words
BOSTON -- The increased risk of HIV infection observed in the now-defunct trial of Merck's experimental trivalent HIV vaccine V520 was greatest in un-circumcised men with high preexisting immunity to the vaccine's delivery vector, the adenovirus type 5, according to a post hoc analysis of the trial
Solving Decades-Old Mystery Killed Virus is Reason for RSV Vaccine Failure.
Magazine article from: BIOWORLD Today Breindl, Anette December 18, 2008 700+ words
Byline: Anette Breindl, Science Editor Work in the Dec. 14, 2008 issue of Nature Medicine solves an old riddle: Why a 1960's vaccine for respiratory syncytial virus, far from being protective, instead exacerbated disease -- a misadventure which, senior author Fernando Polack told BioWorld Today,
Varicella vaccine fails to protect against infection.
Newspaper article from: Vaccine Weekly January 29, 2003 700+ words
...risk factors for vaccine failure was restricted to...greater risk for vaccine failure than those who had...increased risk of vaccine failure. Breakthrough infections...article was prepared by Vaccine Weekly editors from staff...
For more facts and information, see all results

Source: HighBeam Research, Vaccine failure contributes to mumps outbreak in vaccinated children.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA